Method of determining human chorionic gonadotropin (HCG) in the

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

23230B, 424 12, 422 61, G01N 3356, G01N 3348

Patent

active

043159087

ABSTRACT:
A method of determining human chorionic gonadotropin (HCG) in the urine. The urine to be tested is absorbed on an absorbent body. HCG is determined on the absorbent body by a radioimmunoassay method.

REFERENCES:
patent: 4016250 (1977-04-01), Saxena
patent: 4033723 (1977-07-01), Givner et al.
patent: 4071314 (1978-01-01), Prugnaud
patent: 4123509 (1978-10-01), Banik et al.
patent: 4138214 (1979-02-01), Givner
patent: 4200436 (1980-04-01), Mochida et al.
patent: 4208187 (1980-06-01), Givner
patent: 4234561 (1980-11-01), Bahl

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of determining human chorionic gonadotropin (HCG) in the does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of determining human chorionic gonadotropin (HCG) in the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining human chorionic gonadotropin (HCG) in the will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-942578

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.